Clinical Trials Browser

Phase 3 × Infusions, Intravenous × 1 year × Clear all

NCT06505837 2025-08-28

JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）

Phase 3 Active not recruiting

Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer